BRIEF published on 11/26/2024 at 17:50, 1 year 8 months ago Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
PRESS RELEASE published on 11/26/2024 at 17:45, 1 year 8 months ago Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF published on 10/10/2024 at 07:05, 1 year 9 months ago Valneva presents its outlook at an investor day in New York Investors Growth Valneva Vaccines Lyme
PRESS RELEASE published on 10/10/2024 at 07:00, 1 year 9 months ago Valneva Hosts Investor Day in New York City Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines
BRIEF published on 10/04/2024 at 07:35, 1 year 9 months ago Valneva SE Announces Changes in Shares and Voting Rights Euronext Paris Voting Rights Shares Capital Increase Valneva SE
PRESS RELEASE published on 10/04/2024 at 07:30, 1 year 9 months ago Valneva SE - Declaration of shares and voting rights - September 30, 2024 Valneva declares changes in shares and voting rights, including a transfer into bearer form and a capital increase without preferential subscription rights Voting Rights Shares Capital Increase Transfer Valneva
BRIEF published on 10/03/2024 at 07:05, 1 year 9 months ago Valneva to Hold Investor Day in New York New York Investors Valneva Vaccines Chikungunya
PRESS RELEASE published on 10/03/2024 at 07:00, 1 year 9 months ago Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET Valneva SE to host Investor Day at Lotte New York Palace Hotel on Thursday, October 10, 2024, focusing on R&D pipeline and revenue-generating vaccines Investor Day Valneva SE Vaccine R&D Pipeline Lotte New York Palace Hotel
BRIEF published on 09/23/2024 at 15:51, 1 year 10 months ago Valneva Bolstered by Capital Raise Amid Strategic Focus on Vaccine Development BUY Rating Valneva SE Vaccine Development Equity Research Capital Raise
PRESS RELEASE published on 09/23/2024 at 15:46, 1 year 10 months ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Valneva SE (FR0004056851) with a BUY rating and a decreased price target to €7.70, reflecting the recent capital raise completed on 13 September 2024 BUY Rating Price Target Valneva SE Equity Research Capital Raise
Published on 08/01/2026 at 01:20, 1 day 14 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 14 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 15 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 16 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 7 hours 30 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 23 hours 10 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 19 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 20 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 18 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 20 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 21 hours ago Covivio Hotels - 2026 Half-year financial report
